Abstract
Background: Respiratory tract infections caused by viruses are among the most common diseases in humans worldwide. The diagnosis remains difficult as the symptoms overlap significantly with each other.
Objectives: The objective of this study is to identify the respiratory viruses other than SARS-CoV- -2 causing Influenza-like illness (ILI) /severe acute respiratory infection (SARI) during COVID-19 pandemic.
Methods: A total of 100 samples, including COVID-19 positive (n=50) and negative (n=50), were included in the study. The detailed case record form was filled for each patient including relevant history. Nasopharyngeal and Oropharyngeal swabs were subjected to standardized RT-PCR for the detection of SARS-CoV-2 followed by Multiplex RT-PCR for other respiratory viruses.
Results: Other respiratory viruses causing ILI/SARI symptoms similar to SARS-CoV2 during COVID-19 pandemic in non-COVID-19 patients aged more than 18 years were found to be Human metapneumovirus (2%), Human adenovirus (1%), Human parainfluenza virus-1 (1%). The result suggested that other respiratory viral infections are significantly higher among COVID-19 negative individuals presenting with respiratory illness as compared to COVID-19 positive individuals, possibly due to viral interference and competitive advantage of SARS-CoV-2 in modulating the host immune system.
Conclusion: The other respiratory viruses in SARS-CoV-2 negative patients had mild to moderate ILI/SARI symptoms, which usually do not require hospitalization but need to be monitored, especially in high-risk patients. Human metapneumovirus, Adenovirus, Parainfluenza virus-1 most commonly occured in more than 60 years age group with comorbidity which can be useful in stratification for future surveillance of other respiratory viruses in health care settings.
[http://dx.doi.org/10.1002/jmv.25674] [PMID: 31944312]
[http://dx.doi.org/10.1186/s12879-020-05383-y] [PMID: 32948121]
[http://dx.doi.org/10.3390/ijerph17238994] [PMID: 33276678]
[http://dx.doi.org/10.1007/s13337-022-00761-3] [PMID: 35411310]
[http://dx.doi.org/10.3389/fmicb.2021.723850] [PMID: 34531842]
[http://dx.doi.org/10.3390/tropicalmed7060110] [PMID: 35736988]
[http://dx.doi.org/10.4103/ijmr.IJMR_1788_20] [PMID: 32773414]
[http://dx.doi.org/10.1001/jama.2020.6775] [PMID: 32320003]
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[http://dx.doi.org/10.1155/2021/5313832] [PMID: 34485513]
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[http://dx.doi.org/10.4081/monaldi.2020.1294] [PMID: 32290644]
[http://dx.doi.org/10.1186/s12879-021-05814-4] [PMID: 33494706]
[PMID: 35350252]
[http://dx.doi.org/10.1038/s41598-023-33627-9] [PMID: 37072619]
[http://dx.doi.org/10.1038/s41598-021-03987-1] [PMID: 34997042]
[http://dx.doi.org/10.3390/ijerph18189525] [PMID: 34574450]
[http://dx.doi.org/10.3390/vaccines8040587] [PMID: 33036202]
[http://dx.doi.org/10.1002/jmv.27102] [PMID: 34032294]